Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.
about
Menopause, obesity and inflammation: interactive risk factors for Alzheimer's diseaseMediators of inflammation in polycystic ovary syndrome in relation to adiposityInsulin stimulates interleukin-6 expression and release in LS14 human adipocytes through multiple signaling pathwaysCoronary artery disease and its association with Vitamin D deficiencyThe potential role of biomarkers in predicting gestational diabetesWhat is the impact of n-3 PUFAs on inflammation markers in Type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized controlled trialsEffects of walking on low-grade inflammation and their implications for Type 2 DiabetesMechanisms of chronic JAK-STAT3-SOCS3 signaling in obesityAdipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokinesBiomechanical factors in osteoarthritisNo evidence for a role of adipose tissue-derived serum amyloid a in the development of insulin resistance or obesity-related inflammation in hSAA1(+/-) transgenic miceChronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese MiceInflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical ImplicationsThe role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancyDietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expressionMacrophage function in obesity-induced inflammation and insulin resistance.Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humansFemale mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue.Cardiovascular disease could be contained based on currently available data!Circulating markers of inflammation and their link to indices of adiposityCaloric restriction with or without exercise: the fitness versus fatness debate.IL-6 regulates adipose deposition and homeostasis in lymphedema.Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk preventionAn epidemiological investigation into the association between biomarkers and growth performance in nursery pigs.In case of obesity, longevity-related mechanisms lead to anti-inflammation.Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-reviewImmune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue.Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target.Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives.Relationship of ghrelin, acid uric and proinflammatory adipocytokines in different degrees of obesity or diabetesRegional adipose tissue hormone/cytokine production before and after weight loss in abdominally obese women.Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise trainingIL-6 in diabetes and cardiovascular complications.Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.Chronic inflammation in obesity and the metabolic syndrome.Addition of aerobic exercise to a weight loss program increases BMD, with an associated reduction in inflammation in overweight postmenopausal womenThe effective fraction isolated from Radix Astragali alleviates glucose intolerance, insulin resistance and hypertriglyceridemia in db/db diabetic mice through its anti-inflammatory activity.The association between BMI and plasma cytokine levels in patients with acute lung injury.Effects of pioglitazone mediated activation of PPAR-γ on CIDEC and obesity related changes in mice.
P2860
Q21131065-B5D6D120-C09A-485D-9399-F761065AE572Q21296837-9864ED07-5B9E-4C80-9BEA-992FCDEF2FA5Q24656266-4931C2F4-2CF9-4A97-81E8-4EEE2BA09202Q26738686-EBE62B3C-7998-4A22-8A93-EB75FCD60E7EQ26739013-C029BF39-4A52-4F34-9974-0F0391A5D678Q26740239-2E13BDBE-4B93-4F69-9822-705ABC61F4CAQ26769053-13EBBF6F-0FAA-4B98-B89F-E102D25F7308Q26850181-DC35E16A-93C5-4A35-BB5F-A3A475E6E66AQ27001148-706B19BC-E455-43E4-9687-64DB20205C71Q27026034-64D74BEF-1A32-43C9-A064-356A6DF1A3BBQ27309035-3E46A3A0-BDA8-466D-8414-1D7097C90FCBQ27336446-9A8854F3-479D-48A1-9F12-377732E2B104Q28066646-D5B19B9E-5113-420D-9D93-A213B5411F33Q28730838-0D045223-007C-4D0A-89BF-540B5BAFA119Q29615766-1C17C9D9-C77B-4C03-B116-C0C9C3EF58F4Q30235587-402C1397-077F-4F03-AD3C-EFB59DFB7310Q30428503-A10A4698-7B5E-4C42-9570-362CEE9EA970Q31103663-F194C47C-A179-4D6A-8866-659637CCAE27Q31164692-A374DDBD-A8FC-4A95-9622-073455AC156FQ33575903-F109D966-78A6-437A-BDCB-4842D29B97C0Q33589574-13893081-1D58-41CD-856A-3FB7395BA03BQ33626518-942F51A9-4E07-4D89-88D0-6B4434EE6FFDQ33627732-23A9BE04-31F3-4002-9F96-749120272C4FQ33643820-D51D7C23-4F33-46A5-A057-A4B495676288Q33689066-E8C4457F-7221-4606-9642-09BD49E8A7DFQ33708384-339F80CA-55D1-4911-AF66-78E13E126D42Q33731768-F0DB2DEB-232C-4D47-A0DC-4CD49EC84D8AQ33774339-F18E0B1E-95B3-472E-AC1D-13BB7EB16D24Q33774610-156E80FD-E018-4F4E-AA58-AAF2588FDC76Q33802207-8A7A8A09-9382-4A1E-AD30-4276545E0B10Q33816021-15987106-C420-406A-8162-61A8C43DF7F0Q33831518-5898B62F-321D-4416-83EF-14DA11943184Q33938878-AE9BACA0-B29A-406F-AFB4-E4208645E309Q34025142-BEEF8555-AAB2-4DAD-8BFA-41463B3249AAQ34031701-89FA9AC0-6CD0-4D33-9F64-E5729B000011Q34035348-C03E2747-3910-4B39-BD25-EB173B7A8D16Q34080333-F5BEA579-9F94-4E86-9151-22483C7FB39BQ34114709-6DC3E1C6-E4ED-4402-AEE5-D39BCCB41E63Q34130717-9A5B8E30-CE29-4BC8-B189-835949BA2F31Q34166119-0D242833-4801-4344-A1C6-969D003E6B9B
P2860
Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Elevated levels of interleukin ...... obese women after weight loss.
@ast
Elevated levels of interleukin ...... obese women after weight loss.
@en
type
label
Elevated levels of interleukin ...... obese women after weight loss.
@ast
Elevated levels of interleukin ...... obese women after weight loss.
@en
prefLabel
Elevated levels of interleukin ...... obese women after weight loss.
@ast
Elevated levels of interleukin ...... obese women after weight loss.
@en
P2093
P356
P1476
Elevated levels of interleukin ...... obese women after weight loss
@en
P2093
Bastard JP
Bruckert E
P304
P356
10.1210/JCEM.85.9.6839
P407
P50
P577
2000-09-01T00:00:00Z